Status:
TERMINATED
Effects of a Supplement Enriched in Hydroxymethylbutyrate and Vitamin D on Muscle Strength in Hip Fracture
Lead Sponsor:
Hospital Clinic of Barcelona
Collaborating Sponsors:
Abbott
Conditions:
Hip Fractures
Eligibility:
All Genders
65+ years
Phase:
PHASE4
Brief Summary
The purpose of this study is to determine whether a nutritional supplement high in protein and energy, and enriched with hydroxymethylbutyrate (HMB) and vitamin D is more effective than a standard nut...
Detailed Description
Hip fractures are the cause of substantial morbidity and mortality in elderly people. Nine months after hip fracture, patients still have a poorer quality of life compared to control subjects matched ...
Eligibility Criteria
Inclusion
- Patients over 65 years of age after hip fracture surgery.
- Ability to walk before fracture.
Exclusion
- Chronic renal failure, defined as a glomerular filtration rate less than 60 mL/min/1.73 m2, or serum creatinine of 0.9 mg/dL in women or 1.2 mg/dL in men.
- Following a diet with protein restriction.
- Need for enteral or parenteral nutrition.
- Need for medication with orexigenic or anabolic effect, or long-term corticosteroids.
- Active neoplastic disease.
- Cognitive impairment or major psychiatric disorder.
- Lack of signed informed consent.
- Any patient with inability to comply with treatment or not appropriate according to the investigator.
Key Trial Info
Start Date :
June 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2015
Estimated Enrollment :
2 Patients enrolled
Trial Details
Trial ID
NCT01850251
Start Date
June 1 2013
End Date
March 1 2015
Last Update
August 19 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Clinic de Barcelona
Barcelona, Catalonia, Spain, 08036